Clarity in cell line development

Postcard from BPI Europe in Vienna – Highlights of the Cell Line Development Stream

This annual meeting in early Spring is always a good forum for major new product and technology announcements. In previous years, discussions often mainly centred around assurance of clonality and the requirements of the FDA – still a key consideration for cell line development. Recently, however, the market has expanded from a focus on monoclonal …

Read more Postcard from BPI Europe in Vienna – Highlights of the Cell Line Development Stream